{
    "type": "ETP",
    "ucits": false,
    "replication_method": "synthetic",
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": true,
    "complex_factors": [
        "Leverage",
        "Inverse Exposure",
        "Synthetic Replication",
        "Use of Collateral and Margin Accounts",
        "Daily Rebalancing and Compounding Effects",
        "Counterparty Risk"
    ],
    "classification": "complex",
    "supporting_data": "The product is a Collateralised Exchange Traded Security (ETP) designed to provide -5x the daily performance of the S&P 500 Index, indicating significant leverage and inverse exposure. The replication is synthetic, as the underlying assets are held in a margin account including securities loans and collateral assets, rather than direct physical ownership of the index constituents. The product uses swaps or similar derivative instruments to achieve the leveraged inverse exposure, as evidenced by references to collateral, margin accounts, and the issuer's payment obligations being funded by liquidating collateral assets. The product has a very high risk rating of 7/7, the highest possible, reflecting the complexity and risk of leveraged inverse ETPs. The KIID explicitly warns about the compounding effect due to daily rebalancing, which can cause returns over periods longer than one day to deviate significantly from the expected multiple of the underlying index return. The product is not UCITS compliant, which often implies fewer investor protections and more complex structures. The PRIIPs KID and factsheet confirm the use of synthetic replication and leverage, and the product is intended only for sophisticated investors able to monitor positions daily. There is no capital protection, and the product may be difficult to understand for retail investors. These factors combined meet the MiFID II criteria for classification as a complex financial instrument."
}